Who should attend?
CFOs: As the biotech landscape evolves at unprecedented speed, CFOs find themselves at the center of transformation—not only managing capital, but shaping strategic direction. At ABFO, financial leaders will gain critical insights into emerging funding dynamics, M&A priorities and regulatory shifts that directly influence long term financial planning. You will walk away with a clearer understanding of how to balance innovation investment with disciplined fiscal governance, how to position your organization in a competitive capital market, and how to leverage partnerships, data, and operational models that accelerate growth. Ultimately, ABFO equips CFOs with the strategic foresight and practical tools needed to guide their companies through the next wave of scientific and market opportunity.
Aspiring CFOs: For future CFOs, ABFO offers a front row seat to the forces shaping the industry—and a clear view of the skills and strategic mindset required to lead in it. Attendees will gain exposure to evolving capital raising models and the financial frameworks that drive biotech from early discovery through commercialization. They’ll see firsthand how seasoned CFOs navigate uncertainty, build investor confidence, and translate complex science into clear value narratives.
More importantly, aspiring CFOs will leave with a deeper understanding of the competencies they must hone: strategic financial planning in a high risk, high reward environment; cross functional collaboration with R&D and clinical teams; and the ability to anticipate regulatory, market, and operational pressures before they materialize. The conference serves not just as an educational experience, but as a roadmap—illuminating the path toward becoming a financial leader who can guide a biotech organization through growth, challenges, and breakthrough moments.